Home Drug Codes J Codes J3396 · VISUDYNE
Updated July 1st, 2026

VISUDYNE J Code: J3396

Injection, verteporfin, 0.1 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J3396, effective October 1, 2026: $11.342 per HCPCS billing unit, down 0.3% from $11.374. From CMS's final file.

?
Medicare Payment Limit ?
$11.374
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$11.374
/ HCPCS billing unit · APC 1203
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, verteporfin, 0.1 mg
HCPCS Added Date January 1, 2005
Manufacturer Bausch Health
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Solution

About VISUDYNE

Visudyne is a medication aligned to the HCPCS J Code: J3396 for billing, pricing, and reimbursement purposes in the United States. This Ophthalmology medication is administered via the intravenous route and manufactured by Bausch Health.

According to CMS Drug Use Information: Verteporfin is used along with laser light treatment to treat certain serious eye conditions (such as macular degeneration, pathologic myopia, ocular histoplasmosis). It is used to help prevent decreased vision and blindness. After you have received the injection of verteporfin, your doctor will use laser light treatment on the affected eye(s). The laser light will change the drug to a form that works by damaging only those cells that cause the serious eye problem.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00187-5600-15 Visudyne Bausch Health US LLC 150 15 MG
24208-0560-15 Visudyne Bausch & Lomb Incorporated 150 15 MG
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

VISUDYNE Pricing & Reimbursement

J3396 Private Payer Reimbursement
$11.47 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

VISUDYNE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Visudyne (J3396) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

VISUDYNE Medically Unlikely Edits (MUE)

The most billing units of J3396 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.1 mg.

Practitioner Office & Hospital Outpatient
150 units / day
= 15 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

VISUDYNE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

subfoveal choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) subfoveal choroidal neovascularization (CNV) due to pathologic myopia subfoveal choroidal neovascularization (CNV) due to presumed ocular histoplasmosis
Drug Class
Photoabsorption [MoA]Photoenhancer [EPC]Photosensitizing Activity [PE]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Visudyne billing and coding guide?
Billing and coding information for VISUDYNE can be found through Bausch + Lomb. Visit Here →
Are there any available Visudyne patient assistance programs?
VISUDYNE patient assistance information can be found through Bausch + Lomb. Visit Here →
Where can I find Visudyne prescribing information?
VISUDYNE prescribing information can be found at the link below: Visit Here →
Where can I find Visudyne side effect information?
Information regarding VISUDYNE's side effects can be found at MedlinePlus Visit Here →
Does billing VISUDYNE require JZ/JW wastage modifiers?
CMS has identified VISUDYNE(J3396) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.